American Biotech Company Donates 1.5 Million Doses of Potential Coronavirus Drug Remdesivir

The American biotech company Gilead Sciences Inc. is donating 1.5 million doses of a potential coronavirus cure to hospitals across the nation. The experimental antiviral treatment remdesivir has already been accepted for use on coronavirus patients by the European Union’s health regulator. Remdesivir is used to stop infected cells from reproducing nearly any virus — … Continue reading American Biotech Company Donates 1.5 Million Doses of Potential Coronavirus Drug Remdesivir